drug elimination and efficacy vs. potency Flashcards Preview

Boards: Pharm and Biostats > drug elimination and efficacy vs. potency > Flashcards

Flashcards in drug elimination and efficacy vs. potency Deck (11):
1

zero order elimination: definition, graph, examples

rate of elim is constant regardless of the concentration- a fixed amount of drug is elimiated. concentration decr. linearly with time. key examples: phenytoin, ethanol, and toxic high aspirin doses

2

What should I know about urine pH and drug elimination

ionized species are trapped in urine, while neutral species may be reabsorbed

3

weak acidic drugs and urine: examples, when are they trapped, overdoses

phenobarbitol, methotrexate, and aspirin. they are trapped in basic environment. treat overdose with bicarb.

4

weakly basic drugs and urine: examples, when are they trapped, and overdoses

examples: amphetamines. trapped in acidic environments. treat overdoses with ammonium chloride.

5

drug metabolism phase I

reduction, oxidation, hydrolysis with P-450 system usually leaves slightly polar water soluble metabolites that are often still active. geriatric patients loose this stage of metabolism first.

6

drug metabolism phase II

conjugation (glucuronidation, acetylation, and sulfation) usually yields highly polar inactive metabolites. these drugs are renally excreted. geriatric patients are still able to do phase II drug metabolism. slow aceylators often have greater side effects from certain drugs bc of decr. metab.

7

Efficacy

maximal effect that a drug can produce. parital agonists have less efficacy than full agonists

8

Potency

the amt of drug needed for a given effect. high potency drugs have a greater affinity for their receptors (think of chemo drugs, BP drugs, and cholesterol drugs)

9

How will a competitive antagonist change a receptor binding curve?

curve will be shifted to the right, as affinity decreases. this indicates reduced potency without a change in efficacy. it can be overcome by incr. conc. of the agonist substrate

10

How will a non-competitive antagonist change a receptor binding curve?

it will decrease the efficacy of the drug. it cannot be overcome by incr. agonist substrate concentration

11

How will a partial agonist change a receptor binding curve

acts at at the same site as a full agonist, but with lower maximal effect (decr. efficacy). potency is an independent variable